No Carolina / NY / Florida
Ph: 561.316.3330

spot_img

Sphere Fluidics Awarded Gold Accreditation by Investors in People

Dale Levitzke, CEO of Sphere Fluidics, expressed his pride in the achievement: "Receiving the Gold Investors in People Award is a significant milestone for Sphere Fluidics. It recognizes the dedication and hard work of our entire team in creating a workplace where people feel valued, supported, and empowered to reach their full potential. This award is not just a tribute to our HR practices, but a testament to our commitment to nurturing a culture of excellence and continuous improvement."

World’s 1st Healthcare Metaverse from DeHealth

Summation

  • The company announced the start of the creation of a Decentralized Metaverse, which will take millions of doctors and patients to a new world where they can work, interact with each other in full 3D format and earn virtual assets by selling their anonymized medical data.
  • “Our goal is to provide people with the most advanced technologies to preserve their health so that every person in the world, regardless of the place of residence, social status, and financial capabilities, can control their health and life.
  • The user’s ability to transfer their digital identity (avatar), including all medical data collected through other digital platforms, into the new virtual world without problems will be critical to the success of the DeHealth metaverse.

A British non-profit organization, DeHealth, is revolutionizing the healthcare industry. The company announced the start of the creation of a Decentralized Metaverse, which will take millions of doctors and patients to a new world where they can work, interact with each other in full 3D format and earn virtual assets by selling their anonymized medical data.

The HLT (health) token will become the main mean of settlement within the ecosystem that will power it from the inside.

The DeHealth Metaverse will be an extension of the VR, AR, and Mixed Reality (MR) technologies. It will allow several participants, for instance, a doctor and a patient, to communicate via one virtual space, assimilating the real-world situation.

The user’s ability to transfer their digital identity (avatar), including all medical data collected through other digital platforms, into the new virtual world without problems will be critical to the success of the DeHealth metaverse.

Anna Bondarenko, the Co-Founder DeHealth commented: “Our goal is to provide people with the most advanced technologies to preserve their health so that every person in the world, regardless of the place of residence, social status, and financial capabilities, can control their health and life. The future of healthcare lies not in treatment but the prevention of diseases. Our AI will notice the slightest deviations from the human norm and warn about it. Thanks to HLT, each person in the metaverse can sell their impersonal medical information with their own hands.”

Denys Tsvaig, the Co-Founder of DeHealth, commented: “To implement our metaverse, we will use a new technological stack: the Hospital OS digital platform, the blockchain network (cryptoeconomics of the HLT Network), fundamentally different AR / VR devices, electronic clothing, 5G communication networks, quantum computing & communications, cybersecurity, data storage chips using synthetic biology and so much more. The metaverse may require a new programming model that resembles a living and open developing platform, where millions of users seamlessly move from one world to another using the avatar of themselves.”

The DeHealth metaverse will be supported by a wide range of devices – from smartphones and PCs to mixed types of headsets.

Holders of HTL tokens will become the first investors and leaders of the new trend in healthcare.

A preliminary version of the metaverse will be available in late 2022. It will open up access to 3 million Hospital OS users, DeHealth said.

Inspira Receives 1st Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

Inspira reports the first units are expected to be shipped in Q4 2024. The Purchase Order follows the recent FDA Clearance of the INSPIRA™ ART100.

Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility

The purchase order includes deliveries for both the 10mL and 50mL specialty copolymer prefillable syringes that will be manufactured at the West Columbia site being acquired from Nephron. This assurance of supply is expected to support the planned expansion of the 503b operations at the Nephron site. The new copolymer syringe technology reflects the pharmaceutical and healthcare industry’s trend toward transitioning injectable drug therapies into innovative polymer prefillable syringes and away from the older glass and standard plastic syringes reports Sharps Technology.

CIONIC Unveils Three New Centers of Excellence on the East Coast to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and Neuromodulation

Jeremiah Robison, CIONIC Founder & CEO. "We are proud to work with IMSMP, Jersey Shore University Medical Center, and MedStar Health to deliver a unified care experience with the Neural Sleeve from the clinic to the home, setting a new standard for mobility care."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
SourceDeHealth

By using this website you agree to accept Medical Device News Magazine Privacy Policy